-
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100
Louis Fox, Marieke van Leeuwen, Jennifer M. Jones, Amal Al‐Omari, Haneen Abaza, Muna Alkhaifi, +57 more
2citations -
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Nicole D Hildebrand, David P.J. van Dijk, Jisce R. Puik, Anne Claire Henry, Paul C. M. Andel, Esther N. Dekker, +28 more
1citations -
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
Marit Ahrens, John B.A.G. Haanen, Laurence K. Albiges, Marine Gross‐Goupil, Ekaterini Boleti, Gwénaëlle Gravis, +29 more
1citations -
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways
Lotte L. Hoeijmakers, Elisa A. Rozeman, Marta López‐Yurda, Lindsay G. Grijpink-Ongering, Birthe C. Heeres, Bart A. van de Wiel, +10 more
1citations -
Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Merlijn U.J.E. Graus, Aniek E. van Diepen, Thijmen H.T. Broekman, Casper W.F. van Eijck, Jeanin Elise van Hooft, Marjolein Y.V. Homs, +6 more
1citations -
Standardising definitions, endpoints, and reporting parameters for clinical studies of stereotactic body radiation therapy in bone metastases: An international Delphi consensus
Shing Fung Lee, Henry C. Y. Wong, Eva Oldenburger, Srinivas Raman, Gustavo Nader Marta, Adrian W. Chan, +18 more
1citations -
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis2025 European Journal of Cancer article Mathematics Statistical Methods in Clinical Trials Open access
Alexander Dean Sherry, Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, +6 more
1citations -
Association of germline genetic variants with breast cancer survival in patient subgroups defined by standard clinic-pathological variables2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer
Anna Morra, Maria Escala-Garcia, Sander Canisius, Renske Keeman, Montserrat García‐Closas, Paul D.P. Pharoah, +1 more
1citations -
Response to letter Re: Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors
A. Özkan, Karlijn de Joode, Ellen Kapiteijn, Marije Slingerland, Stephanie M. Zunder, Frederiek van den Bos, +11 more
1citations -
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Alexander C. J. van Akkooi, Michal Kiciński, Anne-Sophie Govaerts, Axel Hauschild, Piotr Lukasz Rutkowski, Petr Arenberger, +32 more
1citations -
Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Thijmen H.T. Broekman, Tara M. Mackay, Judith de Vos‐Geelen, Geert A. Cirkel, Merlijn U.J.E. Graus, Jan‐Willem B. de Groot, +9 more
0citations -
Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maartje van Seijen, Esther H. Lips, Liping Fu, Frederieke H van Duijnhoven, A.M. Thompson, P.H.M. Elkhuizen, +3 more
0citations -
Arcagen: Molecular profiling of rare cancer patients – analysis of the pilot study (87 patients)2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Marie Morfouace, Isabel Ray-Coquard, Nicolas M Girard, Aleksandra Stevovic, Isabelle Treilleux, Pierre Méeus, +12 more
0citations